ESC 365 - Association of anti-citrullinated peptide antibodies with the progression of aortic stenosis

ESC Professional Premium Access

Association of anti-citrullinated peptide antibodies with the progression of aortic stenosis

Session: Pathophysiology and disease progression in aortic stenosis

Topic: Aortic Valve Stenosis

Speaker: Doctor A. Kim (Seoul, KR)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Ahram Kim

Asan Medical Center, Seoul (Korea (Republic of))

0 follower

7 more presentations in this session

Systemic proinflammatory-profibrotic response in aortic stenosis patients with diabetes and its relationship with myocardial remodeling and clinical outcome

Speaker: Doctor H. Lee (Seoul, KR)

OAT3A1/NKD2 mediates increased calcification of aortic valvular interstitial cells under in vitro conditions of uremia

Speaker: Doctor P. Duesing (Bonn, DE)

Characterisation of metabolic phenotype in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study

Speaker: Doctor S. Monga (Oxford, GB)

Novel assay for quantifying the cholesterol crystal dissolution capacity of serum predicts outcomes in patients with severe aortic stenosis undergoing TAVR

Speaker: Doctor B. Al-Kassou (Bonn, DE)

Novel peripheral blood immune cell populations correlate with disease progression and reveal systemic interactions in severe aortic valve stenosis patients

Speaker: Doctor N. Anousakis-Vlachochristou (Athens, GR)

Access the full session

Pathophysiology and disease progression in aortic stenosis

Speakers: Doctor A. Kim, Doctor H. Lee, Doctor P. Duesing, Doctor S. Monga, Doctor B. Al-Kassou...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources